Objective: Accelerated atherosclerosis associated with an enhanced inflammatory state, which characterizes ankylosing spondylitis (AS), is the leading cause of increased cardiovascular risk. The objective of this study was to assess carotid and TNF-a may predict the occurrence of accelerated atherosclerosis in AS.
INTRODUCTION
Patients with ankylosing spondylitis (AS) have an increased cardiovascular morbidity and mortality [1, 2] . Accelerated atherosclerosis caused by a systemic inflammatory response has been reported to be an important risk factor for increased cardiovascular risk for autoimmune diseases such as rheumatoid arthritis (RA), psoriatic arthritis (PsA) and systemic lupus erythematosus (SLE) [3] . The risk of myocardial infarction increases in younger patients and those with more severe disease (defined by disease activity) even after adjustment for traditional cardiovascular risk factors (hypertension, hyperlipidemia, diabetes, smoking and body mass index) in AS patients [4] . Among the various screening methods, carotid intima-media thickness (CIMT)
according to high-resolution ultrasonography has been established as a clinically useful index for identifying early stage atherosclerosis predicting future cardiovascular events [5] .
In the present study, we assessed carotid intima-media thickness in AS patients with matched healthy controls who did not have traditional cardiovascular risk factors. We also studied the possible correlation between CIMT and disease activity and disease ability indices.
METHODS

Study Subjects
This was a cross-sectional study in which 55 participants were recruited and divided into two groups. Thirty AS patients (9 Values are mean ± SD BMI body mass index, HDL high-density lipoprotein, LDL low-density lipoprotein, ESR erythrocyte sedimentation rate, CRP C-reactive protein, BASDAI Bath Ankylosing Spondylitis Disease Activity Index, ASDAS Ankylosing Spondylitis Disease Activity Score, BASFI Bath Ankylosing Spondylitis Functional Index, CIMT carotid intima-media thickness, TNF-a tumor necrosis factor-a, IL-6 interleukin-6, IL-1 interleukin-1 * P \0.05 thyroid-stimulating hormone, blood sugar and HbA1c were determined using standard commercial kits and urine analysis to detect proteinuria, hematuria and cellular casts.
Inflammatory markers, i.e., the erythrocyte sedimentation rate (ESR), were measured using the Westergren method and C-reactive protein (CRP) level using standard commercial kits. Inflammatory cytokines, tumor necrosis factor (TNF)-a, interleukin (IL)-6 and IL-1 values were also assessed in all subjects by the ELISA method. All patients underwent clinical and biochemical assessment at the time of recruitment. Clinical, biochemical and CIMT assessments were carried out on the same day of recruitment after overnight fasting.
Assessment of Carotid Intima-Media
Thickness All subjects were examined using a high-resolution Doppler ultrasound (HD 11 XE ultrasound machine, Philips Medical System) using a 13-5-MHz linear array transducer in the supine position. The CCA intima-media thickness (IMT) was defined as the average of the maximum IMT of the near and far wall measurements in the distal CCA (1 cm proximal to the carotid bulb). Intima-media thickness was measured at three points on the far walls of both the left and right common carotid arteries (CCA). The three locations were then averaged to produce the mean IMT for each side. All images of the carotid arteries were recorded on the hard disk of the ultrasound system for subsequent analysis and evaluated by a well-experienced radiologist who was blinded to the clinical characteristics of the participants [11] . The subjects had fasted overnight, and they were studied in the morning between 9
and 11 a.m. The intra-and interobserver variability had coefficient of variations is 2.11-2.45%, respectively, for measurements of CIMT.
Statistical Analysis
Continuous data are expressed as the mean ± standard deviation (SD and IL-1, in AS patients was higher than that in healthy controls (P\0.001, 0.001 and \0.001, respectively, Table 1 ). Compared to healthy controls, AS patients exhibited increased CIMT (0.62 ± 0.12 vs. 0.53 ± 0.09 mm, P = 0.006) (Fig. 1) .
Correlation Analysis of CIMT with Clinical Characteristics and Biomarkers of Inflammation in AS Patients
CIMT was positively correlated with age, disease duration, disease activity measures (BASDAI and ASDAS) and inflammatory markers such as ESR, CRP and TNF-a (Table 2) . No significant correlation was observed between CIMT and BMI, BASFI, IL-6 and IL-1 ( Table 2) . Also no significant correlation was observed between CIMT and total cholesterol, HDL, LDL and TG ( [17, 19, 20, [22] [23] [24] . CIMT was positively correlated with increased disease activity, measured using BASDAI scores and ASDAS, in support of the hypothesis that disease activity may influence atherosclerosis in AS patients. A similar, result was confirmed by Hamdi et al. [24] , but different findings have been reported by other authors [17, 19, 20, 22, 23] .
In addition, we also found that increased CIMT was significantly correlated with inflammatory measures (ESR and CRP),
suggesting that systemic inflammation in AS may accelerate the atherosclerotic process. The correlation between CIMT and ESR has been demonstrated by other authors as well [17, 21, 23, 24] , while others did not find a significant correlation [19, 20, 22] . An elevated CRP, one of the best surrogate markers of systemic inflammation, is known to promote endothelial cell activation and atherosclerotic processes [27, 28] . CRP has been a particularly consistent predictor of increased risk for atherosclerosis in the general population. Our study is consistent with this observation; higher CRP levels were correlated with increased CIMT in AS. This finding is also supported by Hamdi and coworkers, who reported that CIMT was correlated with the CRP level [24] . The mean CRP (18.9 ± 22.9) reported by Hamid et al. was comparable to the results of our study. This suggests that higher levels of CRP may contribute to accelerated atherosclerosis in AS.
In the general population, epidemiologic studies have shown that the CRP level is an independent predictor of CV events [29] . However, no correlation has been observed between CIMT and CRP in AS studies with relatively lower CRP levels [20] [21] [22] [23] [24] [25] [26] . We also found that increased CIMT was significantly correlated with TNF-a, suggesting a contribution to progression of increased CIMT in AS. The correlation between CIMT and IL-1
was not significantly correlated in the present study, but it showed a trend toward a positive correlation (P = 0.06). In our study, no correlation was observed between CIMT and IL-6. TNF-a is an important proinflammatory cytokine involved in the pathogenesis of AS and a potential risk factor of cardiovascular risk.
High levels of circulating cytokines TNF-a, IL-6 and IL-1 are in a position to alter the function of distant tissues, including adipose, skeletal muscle, liver and vascular endothelium, to generate a spectrum of proatherogenic changes that includes insulin resistance, a characteristic dyslipidemia, prothrombotic effects, prooxidative stress and endothelial dysfunction [30] . Previously, proinflammatory cytokines (TNF-a, IL-6 and IL-1) had not been measured in any of these studies [17, [20] [21] [22] [23] [24] 26] . However, Choe et al. estimated the serum level of IL-6 and TNF-a and demonstrated that the serum levels of IL-6 in AS patients was significantly different compared to controls, but not in serum levels of TNF-a. Choe et al. did not find any correlation between CIMT and the serum level of IL-6 and TNF-a in AS. This might be due to the shorter disease duration and low disease activity in the patients included in the study [25] . To the best of our knowledge, the impact of TNF-a blockade on CIMT has not been investigated in AS. However, TNF-a blockade has been shown to improve endothelial dysfunction in AS [31, 32] . A study by Porto et al. in 287 consecutive RA patients demonstrated TNF-a blockade is associated with CIMT reduction, probably by lowering inflammation [33] . Another recent study also demonstrated that TNF-a blockade significantly reduced CIMT as compared to DMARDs in PsA patients [34] .
In the present study, we did not find a significant correlation of CMIT with BASFI, BMI and cholesterol levels. BASFI is an index of functionality. Functional disability may occur over a relatively short period of time depending on disease severity. Moreover, BASFI can vary day to day or week to week. Hence, it is not surprising that BASFI did not correlate with CIMT. In keeping with our results, many investigators have not found a correlation between CIMT and BASFI [17, [21] [22] [23] 25] . In our study, BMI and total cholesterol, HDL, LDL cholesterol and triglycerides were similar in both groups, as reported in some other studies [22, 23, 25] 
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